Dr. Hurley is Chairman of RRD International and Chief Scientific Officer of Symphony Evolution. He brings more than 30 years of experience in assisting companies with their regulatory, research, and product development strategies including clinical trial design and analysis, review of preclinical and clinical information, preparation of regulatory documents, and presentations to government regulatory agencies. He has worked on projects that include over 300 therapeutic and diagnostic products, and a number of epidemiologic studies of the long- term effects of drugs and medical devices. Dr. Hurley is a recognized, published educator and authority on research strategy and study design for pharmaceuticals, biologics, and medical devices. He is preeminent in formatting data presentations to communicate clinical outcomes and has presented applications to every FDA division and seen them through approval. Dr. Hurley co-founded BRI International, Inc. in 1971 and guided its growth as both Chairman and Chief Scientific Officer until he merged BRI with Quintiles Transnational, Inc. in 1996. Dr. Hurley served as Chief Scientific Officer of Quintiles until 2001.